5-HT3 receptor antagonists
US9303045B2 · kind B2 · utility
2Cited by
10References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 2013 |
| Grant date | Apr 5, 2016 |
| Priority date | — |
| Expiry date | Jul 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of the formula:that are 5HT3 receptor antagonists and are therefore useful for the treatment of diseases treatable by inhibition of 5HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.